STSS (Sharps Technology) Tax Provision : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sharps Technology Tax Provision?

Sharps Technology's tax provision for the three months ended in Sep. 2024 was $0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Sharps Technology Tax Provision Historical Data

The historical data trend for Sharps Technology's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharps Technology Tax Provision Chart

Sharps Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Tax Provision

0.03

Sharps Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial											-	-	-	-	-

Sharps Technology Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Sharps Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSS) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

N/A

Address

105 Maxess Road, Suite 124, Melville, NY, USA, 11747

Website

https://www.sharpstechnology.com

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Executives

Robert Michael Hayes	director, officer: Chief Executive Officer	75 BROOKSHIRE DRIVE, YOUNGSVILLE NC 27596
Andrew R. Crescenzo	officer: Chief Financial Officer	C/O ENZO BIOCHEM, 527 MADISON AVENUE, NEW YORK NY 10022
Timothy James Ruemler	director	3311 RIVERPARK CT., BENITA SPRINGS FL 34134
Alan R. Blackman	director, officer: CIO and COO	11502 ROBLES DR. REPP PLACE, TEMPLE TERRACE FL 33617
Paul K Danner	director
Soren Bo Christiansen	director	4059 SPRING VALLEY ROAD, DOYLESTOWN PA 18902
Brenda Baird Simpson	director	7336 PRAIRIE STAR COURT,, PARKER CO 80134
Jason L. Monroe	director	14527 LINDALE ROSE LANE, HUMBLE TX 77379
Barry Boris Berler	officer: CTO and Inventor	77 HERZL STREET, RAMAT GAN L3 5244352